Literature DB >> 15048881

Proliferation marker pKi-67 occurs in different isoforms with various cellular effects.

Mirko H H Schmidt1, Rainer Broll, Hans-Peter Bruch, Susan Finniss, Oliver Bögler, Michael Duchrow.   

Abstract

The Ki-67 antigen, pKi-67, is a commonly used proliferation marker in research and pathology. It has been recognized that the protein exists in two different splice variants that differ in one exon. In the current work, we present three new splice variants of human pKi-67 consisting of two naturally occurring isoforms and one atypical version. Additionally, data is presented indicating that alternative splicing of the pKi-67 N-terminus is common in tumor cell lines. Analyzing 93 tissues mainly consisting of brain tumor specimens, we found evidence that long and short isoform can be expressed independently of each other. Induction of mitosis in human peripheral blood mononuclear cells revealed that short pKi-67 appears earlier in the cell cycle than the long isoform and reaches its expression maximum when transcription of the latter sets in. Finally, transfection of mammalian culture cells with exon 7 (specific for the long pKi-67 isoform and not present in the short isoform) in a tetracycline regulated expression system decreased the rate of cell proliferation without affecting the cell cycle. In summary, we present evidence that the pKi-67 N-terminus is differentially spliced resulting in at least five different isoforms with different functions. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15048881     DOI: 10.1002/jcb.20016

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  9 in total

1.  High-level mRNA quantification of proliferation marker pKi-67 is correlated with favorable prognosis in colorectal carcinoma.

Authors:  Thomas Ihmann; Jian Liu; Wolfgang Schwabe; Peter Häusler; Detlev Behnke; Hans-Peter Bruch; Rainer Broll; Ute Windhövel; Michael Duchrow
Journal:  J Cancer Res Clin Oncol       Date:  2004-09-21       Impact factor: 4.553

2.  Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify.

Authors:  Malgorzata A Komor; Thang V Pham; Annemieke C Hiemstra; Sander R Piersma; Anne S Bolijn; Tim Schelfhorst; Pien M Delis-van Diemen; Marianne Tijssen; Robert P Sebra; Meredith Ashby; Gerrit A Meijer; Connie R Jimenez; Remond J A Fijneman
Journal:  Mol Cell Proteomics       Date:  2017-07-26       Impact factor: 5.911

Review 3.  Ki-67: more than a proliferation marker.

Authors:  Xiaoming Sun; Paul D Kaufman
Journal:  Chromosoma       Date:  2018-01-10       Impact factor: 4.316

4.  Splicing imbalances in basal-like breast cancer underpin perturbation of cell surface and oncogenic pathways and are associated with patients' survival.

Authors:  Filipe Gracio; Brian Burford; Patrycja Gazinska; Anca Mera; Aisyah Mohd Noor; Pierfrancesco Marra; Cheryl Gillett; Anita Grigoriadis; Sarah Pinder; Andrew Tutt; Emanuele de Rinaldis
Journal:  Sci Rep       Date:  2017-01-06       Impact factor: 4.379

5.  PRMT5 inhibition disrupts splicing and stemness in glioblastoma.

Authors:  Patty Sachamitr; Jolene C Ho; Felipe E Ciamponi; Wail Ba-Alawi; Fiona J Coutinho; Paul Guilhamon; Michelle M Kushida; Florence M G Cavalli; Lilian Lee; Naghmeh Rastegar; Victoria Vu; María Sánchez-Osuna; Jasmin Coulombe-Huntington; Evgeny Kanshin; Heather Whetstone; Mathieu Durand; Philippe Thibault; Kirsten Hart; Maria Mangos; Joseph Veyhl; Wenjun Chen; Nhat Tran; Bang-Chi Duong; Ahmed M Aman; Xinghui Che; Xiaoyang Lan; Owen Whitley; Olga Zaslaver; Dalia Barsyte-Lovejoy; Laura M Richards; Ian Restall; Amy Caudy; Hannes L Röst; Zahid Quyoom Bonday; Mark Bernstein; Sunit Das; Michael D Cusimano; Julian Spears; Gary D Bader; Trevor J Pugh; Mike Tyers; Mathieu Lupien; Benjamin Haibe-Kains; H Artee Luchman; Samuel Weiss; Katlin B Massirer; Panagiotis Prinos; Cheryl H Arrowsmith; Peter B Dirks
Journal:  Nat Commun       Date:  2021-02-12       Impact factor: 14.919

Review 6.  The intrinsically disorderly story of Ki-67.

Authors:  Lucy Remnant; Natalia Y Kochanova; Caitlin Reid; Fernanda Cisneros-Soberanis; William C Earnshaw
Journal:  Open Biol       Date:  2021-08-11       Impact factor: 6.411

7.  Chromosome clustering in mitosis by the nuclear protein Ki-67.

Authors:  Konstantinos Stamatiou; Paola Vagnarelli
Journal:  Biochem Soc Trans       Date:  2021-12-17       Impact factor: 5.407

8.  Low expression of a few genes indicates good prognosis in estrogen receptor positive breast cancer.

Authors:  Steven Buechler
Journal:  BMC Cancer       Date:  2009-07-20       Impact factor: 4.430

9.  Ki-67 gene expression.

Authors:  Sigrid Uxa; Paola Castillo-Binder; Robin Kohler; Konstanze Stangner; Gerd A Müller; Kurt Engeland
Journal:  Cell Death Differ       Date:  2021-06-28       Impact factor: 15.828

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.